2008
DOI: 10.1590/s1413-81232008000500024
|View full text |Cite
|
Sign up to set email alerts
|

Testicular dysgenesis syndrome and the estrogen hypothesis: a quantitative meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
24
0
1

Year Published

2009
2009
2023
2023

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 29 publications
(28 citation statements)
references
References 85 publications
3
24
0
1
Order By: Relevance
“…Family history has been associated with a higher risk, with certain genetic mutations likely contributing [3,5]. Other factors that may be associated with cryptorchidism include low birth weight for gestational age, as well as maternal smoking, analgesic use and estrogen (DES) exposure during pregnancy [6-8]. …”
Section: Introductionmentioning
confidence: 99%
“…Family history has been associated with a higher risk, with certain genetic mutations likely contributing [3,5]. Other factors that may be associated with cryptorchidism include low birth weight for gestational age, as well as maternal smoking, analgesic use and estrogen (DES) exposure during pregnancy [6-8]. …”
Section: Introductionmentioning
confidence: 99%
“…These compounds have been linked to effects in the aquatic environment such as ovotestes in male fish and a decline in amphibian populations (Petrovic et al, 2002;Sumpter, 1995;Zhang and Zhou, 2005). Martin et al (2007Martin et al ( , 2008 have highlighted concerns that these compounds are affecting human health. Others have suggested that increased exposure to estrogenic compounds is associated with adverse trends in human reproductive health (Kozak et al, 2001;Sharpe and Skakkebaek, 1993;Soto et al, 2005).…”
Section: Introductionmentioning
confidence: 99%
“…The offspring from these pregnancies were shown to be at risk for several medical conditions, such as vaginal adenocarcinoma and malformation of the testes. [12][13][14][15][16][17] In one large cohort study, the median total dose of DES administered to pregnant mothers ranged from 1625 to 10 424 mg (approximately 23-150 mg kg -1 body weight). 18 Although the detailed mechanisms of its action and its pharmacokinetics are not well understood, DES has been shown to bind to ERs.…”
mentioning
confidence: 99%